Selicrelumab Uses, Dosage, Side Effects and more
Selicrelumab is under investigation in clinical trial NCT01008527 (Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100).
| Trade Name | Selicrelumab |
| Generic | Selicrelumab |
| Selicrelumab Other Names | CP 870,893, Selicrelumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
